{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:57:05Z","timestamp":1769821025314,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-022-03101-z","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T10:03:22Z","timestamp":1654769002000},"page":"480-485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Subacute thyroiditis and COVID-19 vaccines: a case\/non-case study"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7026-1079","authenticated-orcid":false,"given":"Montserrat","family":"Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5927-8715","authenticated-orcid":false,"given":"Itziar","family":"Albizua-Madariaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9575-1602","authenticated-orcid":false,"given":"Unax","family":"Lertxundi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3555-1550","authenticated-orcid":false,"given":"Carmelo","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"3101_CR1","doi-asserted-by":"publisher","unstructured":"R.M. Ruggeri, A. Campenn\u00ec, M. Siracusa, G. Frazzetto, D. Gullo, Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones 20 (2021). https:\/\/doi.org\/10.1007\/s42000-020-00230-w","DOI":"10.1007\/s42000-020-00230-w"},{"key":"3101_CR2","doi-asserted-by":"publisher","unstructured":"H. Jiang, X. Chen, L. Wang, X. Qian, Y. Zhang, J. Wu, S. Shao, Subacute thyroiditis complicated with multiple organ failure: a case report. Medicines 101 (2022). https:\/\/doi.org\/10.1097\/MD.0000000000028710","DOI":"10.1097\/MD.0000000000028710"},{"key":"3101_CR3","doi-asserted-by":"publisher","unstructured":"V. Fatourechi, J.P. Aniszewski, G.Z. Fatourechi, E.J. Atkinson, S.J. Jacobsen, Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J. Clin. Endocrinol. Metab. 88 (2003). https:\/\/doi.org\/10.1210\/jc.2002-021799","DOI":"10.1210\/jc.2002-021799"},{"key":"3101_CR4","doi-asserted-by":"publisher","unstructured":"R. Desailloud, D. Hober, Viruses and thyroiditis: an update. Virol. J. 6 (2009). https:\/\/doi.org\/10.1186\/1743-422X-6-5","DOI":"10.1186\/1743-422X-6-5"},{"key":"3101_CR5","doi-asserted-by":"publisher","unstructured":"J. Christensen, K. O\u2019Callaghan, H. Sinclair, K. Hawke, A. Love, K. Hajkowicz, A.G. Stewart, Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID-19: a systematic review. Intern. Med. J. 52 (2022). https:\/\/doi.org\/10.1111\/imj.15432","DOI":"10.1111\/imj.15432"},{"key":"3101_CR6","doi-asserted-by":"publisher","unstructured":"N.L. Bragazzi, A. Hejly, A. Watad, M. Adawi, H. Amital, Y. Shoenfeld, ASIA syndrome and endocrine autoimmune disorders. Best. Pract. Res. Clin. Endocrinol. Metab. 34 (2020). https:\/\/doi.org\/10.1016\/j.beem.2020.101412","DOI":"10.1016\/j.beem.2020.101412"},{"key":"3101_CR7","doi-asserted-by":"publisher","unstructured":"M. S\u00f6zen, \u00d6. Topalo\u011flu, B. \u00c7etinarslan, A. Selek, Z. Cant\u00fcrk, E. Gezer, D. K\u00f6ksalan, T. Bayraktaro\u011flu, COVID-19 mRNA vaccine may trigger subacute thyroiditis. Hum. Vaccin. Immunother. 17 (2021). https:\/\/doi.org\/10.1080\/21645515.2021.2013083","DOI":"10.1080\/21645515.2021.2013083"},{"key":"3101_CR8","doi-asserted-by":"publisher","unstructured":"M.S. Jeeyavudeen, A.W. Patrick, F.W. Gibb, A.R. Dover, COVID-19 vaccine-associated subacute thyroiditis: an unusual suspect for de Quervain\u2019s thyroiditis. BMJ Case Rep. 14 (2021). https:\/\/doi.org\/10.1136\/bcr-2021-246425","DOI":"10.1136\/bcr-2021-246425"},{"key":"3101_CR9","doi-asserted-by":"publisher","unstructured":"S.O. Oyibo, Subacute thyroiditis after receiving the adenovirus-vectored vaccine for coronavirus disease (COVID-19). Cureus 13 (2021). https:\/\/doi.org\/10.7759\/cureus.16045","DOI":"10.7759\/cureus.16045"},{"key":"3101_CR10","doi-asserted-by":"publisher","unstructured":"E.S. Sayg\u0131l\u0131, E. Karakilic, Subacute thyroiditis after inactive SARS-CoV-2 vaccine. BMJ Case Rep. 14 (2021). https:\/\/doi.org\/10.1136\/bcr-2021-244711","DOI":"10.1136\/bcr-2021-244711"},{"key":"3101_CR11","unstructured":"Screening for adverse reactions in EudraVigilance. https:\/\/www.ema.europa.eu\/en\/documents\/other\/screening-adverse-reactions-eudravigilance_en.pdf Accessed 9 Mar 2022."},{"key":"3101_CR12","unstructured":"https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-covid-19\/treatments-vaccines\/vaccines-covid-19\/safety-covid-19-vaccines Accessed 1 Dec 2021"},{"key":"3101_CR13","doi-asserted-by":"publisher","unstructured":"S. Ippolito, D. Gallo, A. Rossini, B. Patera, N. Lanzo, G.F.M. Fazzino, E. Piantanida, M.L. Tanda, SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review. J. Endocrinol. Investig. 29 (2022). https:\/\/doi.org\/10.1007\/s40618-022-01747-0","DOI":"10.1007\/s40618-022-01747-0"},{"key":"3101_CR14","doi-asserted-by":"publisher","unstructured":"C.A. Benbassat, D. Olchovsky, G. Tsvetov, I. Shimon, Subacute thyroiditis: clinical characteristics and treatment outcome in fifty-six consecutive patients diagnosed between 1999 and 2005. J. Endocrinol. Investig. 30 (2007). https:\/\/doi.org\/10.1007\/BF03347442","DOI":"10.1007\/BF03347442"},{"key":"3101_CR15","doi-asserted-by":"publisher","unstructured":"C.C. Mamby, R.R. Love, K.E. Lee, Thyroid function test changes with adjuvant tamoxifen therapy in postmenopausal women with breast cancer. J. Clin. Oncol. 13 (1995). https:\/\/doi.org\/10.1200\/JCO.1995.13.4.854","DOI":"10.1200\/JCO.1995.13.4.854"},{"key":"3101_CR16","doi-asserted-by":"publisher","unstructured":"P. Caron, Thyroiditis and SARS-CoV-2 pandemic: a review. Endocrine 72 (2021). https:\/\/doi.org\/10.1007\/s12020-021-02689-y","DOI":"10.1007\/s12020-021-02689-y"},{"key":"3101_CR17","doi-asserted-by":"publisher","unstructured":"M. Rotondi, F. Coperchini, G. Ricci, M. Denegri, L. Croce, S.T. Ngnitejeu, L. Villani, F. Magri, F. Latrofa, L. Chiovato, Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J. Endocrinol. Investig. 44 (2021). https:\/\/doi.org\/10.1007\/s40618-020-01436-w","DOI":"10.1007\/s40618-020-01436-w"},{"key":"3101_CR18","doi-asserted-by":"publisher","unstructured":"P. Trimboli, C. Cappelli, L. Croce, L. Scappaticcio, L. Chiovato, M. Rotondi, COVID-19-associated subacute thyroiditis: evidence-based data from a systematic review. Front. Endocrinol. 12 (2021). https:\/\/doi.org\/10.3389\/fendo.2021.707726","DOI":"10.3389\/fendo.2021.707726"},{"key":"3101_CR19","doi-asserted-by":"publisher","unstructured":"A. Watad, P. David, S. Brown, Y. Shoenfeld, Autoimmune\/inflammatory syndrome induced by adjuvants and thyroid autoimmunity. Front. Endocrinol. 7 (2017). https:\/\/doi.org\/10.3389\/fendo.2016.00150","DOI":"10.3389\/fendo.2016.00150"},{"key":"3101_CR20","doi-asserted-by":"publisher","unstructured":"A. Vojdani, D. Kharrazian, Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin. Immunol. 217 (2020). https:\/\/doi.org\/10.1016\/j.clim.2020.108480","DOI":"10.1016\/j.clim.2020.108480"},{"key":"3101_CR21","doi-asserted-by":"publisher","unstructured":"R.M. Ruggeri, A. Campenn\u00ec, D. Deandreis, M. Siracusa, R. Tozzoli, P. Petranovi\u0107 Ov\u010dari\u010dek, L. Giovanella, SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives. Expert Rev. Clin. Immunol. 17 (2021). https:\/\/doi.org\/10.1080\/1744666X.2021.1932467","DOI":"10.1080\/1744666X.2021.1932467"},{"key":"3101_CR22","doi-asserted-by":"publisher","unstructured":"M. Tobaiqy, K. MacLure, H. Elkout, D. Stewart, Thrombotic adverse events reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database. Vaccines 9 (2021). https:\/\/doi.org\/10.3390\/vaccines9111326","DOI":"10.3390\/vaccines9111326"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03101-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03101-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03101-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T15:30:05Z","timestamp":1660750205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03101-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["3101"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03101-z","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"assertion":[{"value":"14 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the authors involved in this study give their consent for this article to be published in Endocrine\u2014International Journal of Basic and Clinical Endocrinology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was approved by the institutional review board of Galdakao-Usansolo Hospital.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}